Home / Inspections / 1259762

FDA Inspection 1259762 — Janssen Pharmaceuticals, Inc.

Janssen Pharmaceuticals, Inc. — FEI 1033845

The FDA completed an inspection of Janssen Pharmaceuticals, Inc. on January 24, 2025 in Athens, GA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 24, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Athens, GA (United States)

Facility

Other inspections at this facility

  • 1025904 (NAI Fri Jul 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 867768 (NAI Thu Feb 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 717213 (NAI Fri Feb 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 574811 (NAI Fri Mar 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources